Atonarp

6 articles about Atonarp

• Atonarp Welcomes Nobel Laureate James E. Rothman to its Board of Directors

  7/19/2022

  Atonarp, a leader advancing clinical diagnostics, life science research, semiconductor and industrial process control through digital molecular profiling, announces that James Rothman, Ph.D., has agreed to serve on its board as an independent director.

• Atonarp Announces Advisory Council of Science and Technology Experts to Boost Development of Digital Molecular Profiling

  11/16/2021

  Atonarp announced today the establishment of its first strategic Advisory Council, consisting of nine distinguished science and technology industry leaders.

• Atonarp Announces $50M Series D Financing to Scale its Molecular Sensing and Digital Diagnostics Testing Platforms

  5/18/2021

  Michael Marks, Founding Partner for WRVI Capital, Joins the Atonarp Board and Former Berkeley Lights CFO Shaun Holt Joins as Atonarp's Chief Operating Officer

• Atonarp Inc. Announces $33 Million Series C Funding Round Completion

  8/26/2019

  Atonarp, a hi-tech molecular diagnostics company, announced that it has raised $33 million in an oversubscribed Series C funding round.

• Atonarp and IMA Life Enter Supply Agreement For Pharmaceutical Lyophilization Applications

  11/6/2017

  The AMS solution was developed in collaboration between IMA Life, Atonarp and a major pharma company with purpose-built quantitative instrumentation for the application of freeze-drying and aseptic processing.

• Atonarp Raises $8 Million Series A Round Led By Walden Riverwood Ventures

  8/19/2014